在接受免疫检查点抑制剂治疗的患者中,对身体活动和生存的回顾性队列研究
Nathan H Parker1, Jairo D Ramos2, Ahmad A Tarhini3,4
1Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
概括
治疗前的体力活动与接受免疫检查点抑制剂 (ICI) 的癌症患者的更好的生存率有关. 较高的活动水平显著降低了死亡风险,这表明ICI治疗期间运动的作用是有益的.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 运动科学 运动科学
背景情况:
- 在接受免疫检查点抑制剂 (ICI) 治疗的癌症患者中,身体活动,免疫系统调节和结果之间的相互作用尚未完全理解.
- 在接受ICI治疗的患者中,研究治疗前体力活动与生存之间的关联对于优化治疗策略至关重要.
研究的目的:
- 检查接受ICI的癌症患者自我报告的治疗前身体活动水平和生存结果之间的关系.
- 确定更高的体力活动是否与该患者群体的生存率改善有关.
主要方法:
- 一项回顾性队列研究,涉及930名接受ICI治疗的患者,这些患者在治疗前报告了身体活动和良好表现状态.
- 使用国际体力活动问卷 (IPAQ) 量化体力活动,并表达为每周代谢相当于任务分钟.
- 采用多变量考克斯比例危险模型,估计与增加四分位数的体力活动相关的死亡危险,并对相关共变量进行调整.
主要成果:
- 身体活动四分位数的增加显着与调整后死亡风险的降低有关 (每四分位数的aHR增加:0.89;95%CI,0.82-0.96).
- 与最低四分之一相比,体育活动的第三和最高四分之一患者的死亡风险分别降低了24% (aHR=0.76) 和28% (aHR=0.72),相比之下,最低四分之一的患者的死亡风险降低了24% (aHR=0.76).
- 使用替代体力活动指标和共识指南的灵敏度分析证实了主要发现.
结论:
- 治疗前的体力活动与免疫检查点抑制剂治疗的癌症患者的存活率提高独立相关.
- 身体活动可能是免疫治疗的有希望的辅助策略,以改善患者的治疗结果.
- 需要进一步的研究,包括客观测量和随机对照试验,以证实这些发现,并确定体力活动在ICI治疗中的作用.
相关概念视频
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


